Diabetic nephropathy :: from bench to bedside /
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Science Publishers, Inc.,
2017.
|
| Schriftenreihe: | Nephrology research and clinical developments series.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource : illustrations |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781536102987 1536102989 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn978248730 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 170321s2017 nyua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d EBLCP |d OCLCQ |d OCLCF |d AGLDB |d IGB |d AUW |d BTN |d MHW |d INTCL |d SNK |d G3B |d S8I |d S8J |d STF |d D6H |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ | ||
| 019 | |a 979062587 | ||
| 020 | |a 9781536102987 |q (electronic bk.) | ||
| 020 | |a 1536102989 |q (electronic bk.) | ||
| 020 | |z 9781536102772 | ||
| 035 | |a (OCoLC)978248730 |z (OCoLC)979062587 | ||
| 050 | 4 | |a RC918.D53 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 7 | |a 616.462 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Diabetic nephropathy : |b from bench to bedside / |c Mingxi Li and Jianling Tao, editors. |
| 264 | 1 | |a New York : |b Nova Science Publishers, Inc., |c 2017. | |
| 300 | |a 1 online resource : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Nephrology research and clinical developments | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Vendor-supplied metadata. | |
| 505 | 0 | |a Preface; New Progress in Diabetic Nephropathy and Local Micro Inflammation; Abstract; Introduction; Diabetic Nephropathy and Local Inflammation; Classic Inflammation in DN; Abnormal Gene Regulation and Local Inflammation in Diabetic Nephropathy; Inflammasome and DN Inflammation; Conclusion; References; Current Findings in The Use of Proteomics Technology for the Diagnosis and Management of Diabetic Nephropathy; Abstract; Introduction; Diabetic Nephropathy; Proteomic Analysis of Diabetic Nephropathy; Proteomic Platforms and Methodologies; Two-Dimensional Gel Electrophoresis (2-De). | |
| 505 | 8 | |a Liquid Chromatography Combined to Mass Spectrometry (Lc-Ms)Quantitative Proteomics; Sample Selection: Advantages and Disadvantages; Urine; Plasma; Lessons from Animal Models; Proteomics in the Clinical Setting: Biomarker Discovery; Conclusion and a Future Place in Therapy; References; Clinical Aspects of Diagnosis and Treatment of DN; Abstract; Introduction; Diagnosis; Clinical Manifestations; Adjunctive labs; Biopsy Indication [3, 15]; Treatment; 1. Lifestyle Modification; 2. Control of Glycated Hemoglobin (Goal of HbA1c: <7.0%); 3. Control of Blood Pressure (Goal of BP: <130/80 mmHg). | |
| 505 | 8 | |a 4. Blockage of RAS5. Improvement in Dyslipidemia; 6. Novel Therapies; Conclusion; References; Diabetic Retinopathy; Abstract; Introduction; Pathophysiology; Classification; Symptoms and Signs; Screening and Diagnosis; Treatment; NPDR; PDR; References; Neurological Diseases in Diabetic Nephropathy; Abstract; Introduction; Central Nervous System Diseases; Uremic Encephalopathy; Dementia and Cognitive Impairment; Cerebrovascular Disease; Osmotic Myelinolysis; Movement Disorders and Restless Legs Syndrome; Opportunistic Infections; Neoplasms; Intracranial Hypotension; Intracranial Hypertension. | |
| 505 | 8 | |a Peripheral Nervous System DiseasesUremic Polyneuropathy; Mononeuropathy; Uremic Myopathy; Autonomic Dysfunction; References; Diabetic Nephropathy and Nutrition; Abstract; Introduction; The Relationship between Nutritional Factors and Diabetic Nephropathy; Nutritional Recommendation for Patients with Diabetic Nephropathy (DN); Glycemic Control; Intake of Protein; Lipid Management; Restriction of Salt Intake; Vitamin D; Dietary Fiber; Dietary Pattern; Nutritional Consideration for End-Stage Renal Disease (ESRD); References; Renal Replacement Therapy in Diabetic Nephropathy; Abstract. | |
| 505 | 8 | |a IntroductionWhen to Start Dialysis; How to Choose Dialysis; I. Long-Term Prognosis and Survival; II. Dialysis Adequacy; III. Residual Renal Function; IV. Complications; A. Cardiovascular Disease; B. Infection; C. Disturbance of Carbohydrate Metabolism and Glycemic Control; Conclusion; References; Clinical Trial Update on the Way to Cure DN; Abstract; Introduction; New Developments in Glycaemic Control and Blood Pressure Control; Glycaemic Control; Blood Pressure Control; New Approaches; Direct Renin Inhibitor; Inhibitors of AGE Formation; Endothelin Antagonists; Bardoxolone Methyl. | |
| 650 | 0 | |a Diabetic nephropathies. |0 http://id.loc.gov/authorities/subjects/sh85037470 | |
| 650 | 2 | |a Diabetic Nephropathies |0 https://id.nlm.nih.gov/mesh/D003928 | |
| 650 | 6 | |a Néphropathies diabétiques. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Diabetic nephropathies |2 fast | |
| 700 | 1 | |a Li, Mingxi, |e editor. | |
| 700 | 1 | |a Tao, Jianling, |e editor. | |
| 776 | 0 | 8 | |i Print version: |a Li, Mingxi. |t Diabetic Nephropathy: From Bench to Bedside. |d Hauppauge : Nova Science Publishers, Inc., ©2017 |z 9781536102772 |
| 830 | 0 | |a Nephrology research and clinical developments series. |0 http://id.loc.gov/authorities/names/n2010181454 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1488015 |3 Volltext |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4825333 | ||
| 938 | |a EBSCOhost |b EBSC |n 1488015 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn978248730 |
|---|---|
| _version_ | 1816882382952726528 |
| adam_text | |
| any_adam_object | |
| author2 | Li, Mingxi Tao, Jianling |
| author2_role | edt edt |
| author2_variant | m l ml j t jt |
| author_facet | Li, Mingxi Tao, Jianling |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC918 |
| callnumber-raw | RC918.D53 |
| callnumber-search | RC918.D53 |
| callnumber-sort | RC 3918 D53 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Preface; New Progress in Diabetic Nephropathy and Local Micro Inflammation; Abstract; Introduction; Diabetic Nephropathy and Local Inflammation; Classic Inflammation in DN; Abnormal Gene Regulation and Local Inflammation in Diabetic Nephropathy; Inflammasome and DN Inflammation; Conclusion; References; Current Findings in The Use of Proteomics Technology for the Diagnosis and Management of Diabetic Nephropathy; Abstract; Introduction; Diabetic Nephropathy; Proteomic Analysis of Diabetic Nephropathy; Proteomic Platforms and Methodologies; Two-Dimensional Gel Electrophoresis (2-De). Liquid Chromatography Combined to Mass Spectrometry (Lc-Ms)Quantitative Proteomics; Sample Selection: Advantages and Disadvantages; Urine; Plasma; Lessons from Animal Models; Proteomics in the Clinical Setting: Biomarker Discovery; Conclusion and a Future Place in Therapy; References; Clinical Aspects of Diagnosis and Treatment of DN; Abstract; Introduction; Diagnosis; Clinical Manifestations; Adjunctive labs; Biopsy Indication [3, 15]; Treatment; 1. Lifestyle Modification; 2. Control of Glycated Hemoglobin (Goal of HbA1c: <7.0%); 3. Control of Blood Pressure (Goal of BP: <130/80 mmHg). 4. Blockage of RAS5. Improvement in Dyslipidemia; 6. Novel Therapies; Conclusion; References; Diabetic Retinopathy; Abstract; Introduction; Pathophysiology; Classification; Symptoms and Signs; Screening and Diagnosis; Treatment; NPDR; PDR; References; Neurological Diseases in Diabetic Nephropathy; Abstract; Introduction; Central Nervous System Diseases; Uremic Encephalopathy; Dementia and Cognitive Impairment; Cerebrovascular Disease; Osmotic Myelinolysis; Movement Disorders and Restless Legs Syndrome; Opportunistic Infections; Neoplasms; Intracranial Hypotension; Intracranial Hypertension. Peripheral Nervous System DiseasesUremic Polyneuropathy; Mononeuropathy; Uremic Myopathy; Autonomic Dysfunction; References; Diabetic Nephropathy and Nutrition; Abstract; Introduction; The Relationship between Nutritional Factors and Diabetic Nephropathy; Nutritional Recommendation for Patients with Diabetic Nephropathy (DN); Glycemic Control; Intake of Protein; Lipid Management; Restriction of Salt Intake; Vitamin D; Dietary Fiber; Dietary Pattern; Nutritional Consideration for End-Stage Renal Disease (ESRD); References; Renal Replacement Therapy in Diabetic Nephropathy; Abstract. IntroductionWhen to Start Dialysis; How to Choose Dialysis; I. Long-Term Prognosis and Survival; II. Dialysis Adequacy; III. Residual Renal Function; IV. Complications; A. Cardiovascular Disease; B. Infection; C. Disturbance of Carbohydrate Metabolism and Glycemic Control; Conclusion; References; Clinical Trial Update on the Way to Cure DN; Abstract; Introduction; New Developments in Glycaemic Control and Blood Pressure Control; Glycaemic Control; Blood Pressure Control; New Approaches; Direct Renin Inhibitor; Inhibitors of AGE Formation; Endothelin Antagonists; Bardoxolone Methyl. |
| ctrlnum | (OCoLC)978248730 |
| dewey-full | 616.462 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.462 |
| dewey-search | 616.462 |
| dewey-sort | 3616.462 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05486cam a2200637 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn978248730</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu|||unuuu</controlfield><controlfield tag="008">170321s2017 nyua ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">N$T</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">AGLDB</subfield><subfield code="d">IGB</subfield><subfield code="d">AUW</subfield><subfield code="d">BTN</subfield><subfield code="d">MHW</subfield><subfield code="d">INTCL</subfield><subfield code="d">SNK</subfield><subfield code="d">G3B</subfield><subfield code="d">S8I</subfield><subfield code="d">S8J</subfield><subfield code="d">STF</subfield><subfield code="d">D6H</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">979062587</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781536102987</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1536102989</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781536102772</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)978248730</subfield><subfield code="z">(OCoLC)979062587</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC918.D53</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">014000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">022000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">112000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">045000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.462</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Diabetic nephropathy :</subfield><subfield code="b">from bench to bedside /</subfield><subfield code="c">Mingxi Li and Jianling Tao, editors.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York :</subfield><subfield code="b">Nova Science Publishers, Inc.,</subfield><subfield code="c">2017.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Nephrology research and clinical developments</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Vendor-supplied metadata.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Preface; New Progress in Diabetic Nephropathy and Local Micro Inflammation; Abstract; Introduction; Diabetic Nephropathy and Local Inflammation; Classic Inflammation in DN; Abnormal Gene Regulation and Local Inflammation in Diabetic Nephropathy; Inflammasome and DN Inflammation; Conclusion; References; Current Findings in The Use of Proteomics Technology for the Diagnosis and Management of Diabetic Nephropathy; Abstract; Introduction; Diabetic Nephropathy; Proteomic Analysis of Diabetic Nephropathy; Proteomic Platforms and Methodologies; Two-Dimensional Gel Electrophoresis (2-De).</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Liquid Chromatography Combined to Mass Spectrometry (Lc-Ms)Quantitative Proteomics; Sample Selection: Advantages and Disadvantages; Urine; Plasma; Lessons from Animal Models; Proteomics in the Clinical Setting: Biomarker Discovery; Conclusion and a Future Place in Therapy; References; Clinical Aspects of Diagnosis and Treatment of DN; Abstract; Introduction; Diagnosis; Clinical Manifestations; Adjunctive labs; Biopsy Indication [3, 15]; Treatment; 1. Lifestyle Modification; 2. Control of Glycated Hemoglobin (Goal of HbA1c: <7.0%); 3. Control of Blood Pressure (Goal of BP: <130/80 mmHg).</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">4. Blockage of RAS5. Improvement in Dyslipidemia; 6. Novel Therapies; Conclusion; References; Diabetic Retinopathy; Abstract; Introduction; Pathophysiology; Classification; Symptoms and Signs; Screening and Diagnosis; Treatment; NPDR; PDR; References; Neurological Diseases in Diabetic Nephropathy; Abstract; Introduction; Central Nervous System Diseases; Uremic Encephalopathy; Dementia and Cognitive Impairment; Cerebrovascular Disease; Osmotic Myelinolysis; Movement Disorders and Restless Legs Syndrome; Opportunistic Infections; Neoplasms; Intracranial Hypotension; Intracranial Hypertension.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Peripheral Nervous System DiseasesUremic Polyneuropathy; Mononeuropathy; Uremic Myopathy; Autonomic Dysfunction; References; Diabetic Nephropathy and Nutrition; Abstract; Introduction; The Relationship between Nutritional Factors and Diabetic Nephropathy; Nutritional Recommendation for Patients with Diabetic Nephropathy (DN); Glycemic Control; Intake of Protein; Lipid Management; Restriction of Salt Intake; Vitamin D; Dietary Fiber; Dietary Pattern; Nutritional Consideration for End-Stage Renal Disease (ESRD); References; Renal Replacement Therapy in Diabetic Nephropathy; Abstract.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">IntroductionWhen to Start Dialysis; How to Choose Dialysis; I. Long-Term Prognosis and Survival; II. Dialysis Adequacy; III. Residual Renal Function; IV. Complications; A. Cardiovascular Disease; B. Infection; C. Disturbance of Carbohydrate Metabolism and Glycemic Control; Conclusion; References; Clinical Trial Update on the Way to Cure DN; Abstract; Introduction; New Developments in Glycaemic Control and Blood Pressure Control; Glycaemic Control; Blood Pressure Control; New Approaches; Direct Renin Inhibitor; Inhibitors of AGE Formation; Endothelin Antagonists; Bardoxolone Methyl.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Diabetic nephropathies.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85037470</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Diabetic Nephropathies</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D003928</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Néphropathies diabétiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Clinical Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Diseases.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Evidence-Based Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Internal Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diabetic nephropathies</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Mingxi,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tao, Jianling,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Li, Mingxi.</subfield><subfield code="t">Diabetic Nephropathy: From Bench to Bedside.</subfield><subfield code="d">Hauppauge : Nova Science Publishers, Inc., ©2017</subfield><subfield code="z">9781536102772</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Nephrology research and clinical developments series.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2010181454</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1488015</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL4825333</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">1488015</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn978248730 |
| illustrated | Illustrated |
| indexdate | 2024-11-27T13:27:44Z |
| institution | BVB |
| isbn | 9781536102987 1536102989 |
| language | English |
| oclc_num | 978248730 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Nova Science Publishers, Inc., |
| record_format | marc |
| series | Nephrology research and clinical developments series. |
| series2 | Nephrology research and clinical developments |
| spelling | Diabetic nephropathy : from bench to bedside / Mingxi Li and Jianling Tao, editors. New York : Nova Science Publishers, Inc., 2017. 1 online resource : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Nephrology research and clinical developments Includes bibliographical references and index. Vendor-supplied metadata. Preface; New Progress in Diabetic Nephropathy and Local Micro Inflammation; Abstract; Introduction; Diabetic Nephropathy and Local Inflammation; Classic Inflammation in DN; Abnormal Gene Regulation and Local Inflammation in Diabetic Nephropathy; Inflammasome and DN Inflammation; Conclusion; References; Current Findings in The Use of Proteomics Technology for the Diagnosis and Management of Diabetic Nephropathy; Abstract; Introduction; Diabetic Nephropathy; Proteomic Analysis of Diabetic Nephropathy; Proteomic Platforms and Methodologies; Two-Dimensional Gel Electrophoresis (2-De). Liquid Chromatography Combined to Mass Spectrometry (Lc-Ms)Quantitative Proteomics; Sample Selection: Advantages and Disadvantages; Urine; Plasma; Lessons from Animal Models; Proteomics in the Clinical Setting: Biomarker Discovery; Conclusion and a Future Place in Therapy; References; Clinical Aspects of Diagnosis and Treatment of DN; Abstract; Introduction; Diagnosis; Clinical Manifestations; Adjunctive labs; Biopsy Indication [3, 15]; Treatment; 1. Lifestyle Modification; 2. Control of Glycated Hemoglobin (Goal of HbA1c: <7.0%); 3. Control of Blood Pressure (Goal of BP: <130/80 mmHg). 4. Blockage of RAS5. Improvement in Dyslipidemia; 6. Novel Therapies; Conclusion; References; Diabetic Retinopathy; Abstract; Introduction; Pathophysiology; Classification; Symptoms and Signs; Screening and Diagnosis; Treatment; NPDR; PDR; References; Neurological Diseases in Diabetic Nephropathy; Abstract; Introduction; Central Nervous System Diseases; Uremic Encephalopathy; Dementia and Cognitive Impairment; Cerebrovascular Disease; Osmotic Myelinolysis; Movement Disorders and Restless Legs Syndrome; Opportunistic Infections; Neoplasms; Intracranial Hypotension; Intracranial Hypertension. Peripheral Nervous System DiseasesUremic Polyneuropathy; Mononeuropathy; Uremic Myopathy; Autonomic Dysfunction; References; Diabetic Nephropathy and Nutrition; Abstract; Introduction; The Relationship between Nutritional Factors and Diabetic Nephropathy; Nutritional Recommendation for Patients with Diabetic Nephropathy (DN); Glycemic Control; Intake of Protein; Lipid Management; Restriction of Salt Intake; Vitamin D; Dietary Fiber; Dietary Pattern; Nutritional Consideration for End-Stage Renal Disease (ESRD); References; Renal Replacement Therapy in Diabetic Nephropathy; Abstract. IntroductionWhen to Start Dialysis; How to Choose Dialysis; I. Long-Term Prognosis and Survival; II. Dialysis Adequacy; III. Residual Renal Function; IV. Complications; A. Cardiovascular Disease; B. Infection; C. Disturbance of Carbohydrate Metabolism and Glycemic Control; Conclusion; References; Clinical Trial Update on the Way to Cure DN; Abstract; Introduction; New Developments in Glycaemic Control and Blood Pressure Control; Glycaemic Control; Blood Pressure Control; New Approaches; Direct Renin Inhibitor; Inhibitors of AGE Formation; Endothelin Antagonists; Bardoxolone Methyl. Diabetic nephropathies. http://id.loc.gov/authorities/subjects/sh85037470 Diabetic Nephropathies https://id.nlm.nih.gov/mesh/D003928 Néphropathies diabétiques. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Diabetic nephropathies fast Li, Mingxi, editor. Tao, Jianling, editor. Print version: Li, Mingxi. Diabetic Nephropathy: From Bench to Bedside. Hauppauge : Nova Science Publishers, Inc., ©2017 9781536102772 Nephrology research and clinical developments series. http://id.loc.gov/authorities/names/n2010181454 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1488015 Volltext |
| spellingShingle | Diabetic nephropathy : from bench to bedside / Nephrology research and clinical developments series. Preface; New Progress in Diabetic Nephropathy and Local Micro Inflammation; Abstract; Introduction; Diabetic Nephropathy and Local Inflammation; Classic Inflammation in DN; Abnormal Gene Regulation and Local Inflammation in Diabetic Nephropathy; Inflammasome and DN Inflammation; Conclusion; References; Current Findings in The Use of Proteomics Technology for the Diagnosis and Management of Diabetic Nephropathy; Abstract; Introduction; Diabetic Nephropathy; Proteomic Analysis of Diabetic Nephropathy; Proteomic Platforms and Methodologies; Two-Dimensional Gel Electrophoresis (2-De). Liquid Chromatography Combined to Mass Spectrometry (Lc-Ms)Quantitative Proteomics; Sample Selection: Advantages and Disadvantages; Urine; Plasma; Lessons from Animal Models; Proteomics in the Clinical Setting: Biomarker Discovery; Conclusion and a Future Place in Therapy; References; Clinical Aspects of Diagnosis and Treatment of DN; Abstract; Introduction; Diagnosis; Clinical Manifestations; Adjunctive labs; Biopsy Indication [3, 15]; Treatment; 1. Lifestyle Modification; 2. Control of Glycated Hemoglobin (Goal of HbA1c: <7.0%); 3. Control of Blood Pressure (Goal of BP: <130/80 mmHg). 4. Blockage of RAS5. Improvement in Dyslipidemia; 6. Novel Therapies; Conclusion; References; Diabetic Retinopathy; Abstract; Introduction; Pathophysiology; Classification; Symptoms and Signs; Screening and Diagnosis; Treatment; NPDR; PDR; References; Neurological Diseases in Diabetic Nephropathy; Abstract; Introduction; Central Nervous System Diseases; Uremic Encephalopathy; Dementia and Cognitive Impairment; Cerebrovascular Disease; Osmotic Myelinolysis; Movement Disorders and Restless Legs Syndrome; Opportunistic Infections; Neoplasms; Intracranial Hypotension; Intracranial Hypertension. Peripheral Nervous System DiseasesUremic Polyneuropathy; Mononeuropathy; Uremic Myopathy; Autonomic Dysfunction; References; Diabetic Nephropathy and Nutrition; Abstract; Introduction; The Relationship between Nutritional Factors and Diabetic Nephropathy; Nutritional Recommendation for Patients with Diabetic Nephropathy (DN); Glycemic Control; Intake of Protein; Lipid Management; Restriction of Salt Intake; Vitamin D; Dietary Fiber; Dietary Pattern; Nutritional Consideration for End-Stage Renal Disease (ESRD); References; Renal Replacement Therapy in Diabetic Nephropathy; Abstract. IntroductionWhen to Start Dialysis; How to Choose Dialysis; I. Long-Term Prognosis and Survival; II. Dialysis Adequacy; III. Residual Renal Function; IV. Complications; A. Cardiovascular Disease; B. Infection; C. Disturbance of Carbohydrate Metabolism and Glycemic Control; Conclusion; References; Clinical Trial Update on the Way to Cure DN; Abstract; Introduction; New Developments in Glycaemic Control and Blood Pressure Control; Glycaemic Control; Blood Pressure Control; New Approaches; Direct Renin Inhibitor; Inhibitors of AGE Formation; Endothelin Antagonists; Bardoxolone Methyl. Diabetic nephropathies. http://id.loc.gov/authorities/subjects/sh85037470 Diabetic Nephropathies https://id.nlm.nih.gov/mesh/D003928 Néphropathies diabétiques. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Diabetic nephropathies fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85037470 https://id.nlm.nih.gov/mesh/D003928 |
| title | Diabetic nephropathy : from bench to bedside / |
| title_auth | Diabetic nephropathy : from bench to bedside / |
| title_exact_search | Diabetic nephropathy : from bench to bedside / |
| title_full | Diabetic nephropathy : from bench to bedside / Mingxi Li and Jianling Tao, editors. |
| title_fullStr | Diabetic nephropathy : from bench to bedside / Mingxi Li and Jianling Tao, editors. |
| title_full_unstemmed | Diabetic nephropathy : from bench to bedside / Mingxi Li and Jianling Tao, editors. |
| title_short | Diabetic nephropathy : |
| title_sort | diabetic nephropathy from bench to bedside |
| title_sub | from bench to bedside / |
| topic | Diabetic nephropathies. http://id.loc.gov/authorities/subjects/sh85037470 Diabetic Nephropathies https://id.nlm.nih.gov/mesh/D003928 Néphropathies diabétiques. HEALTH & FITNESS Diseases General. bisacsh MEDICAL Clinical Medicine. bisacsh MEDICAL Diseases. bisacsh MEDICAL Evidence-Based Medicine. bisacsh MEDICAL Internal Medicine. bisacsh Diabetic nephropathies fast |
| topic_facet | Diabetic nephropathies. Diabetic Nephropathies Néphropathies diabétiques. HEALTH & FITNESS Diseases General. MEDICAL Clinical Medicine. MEDICAL Diseases. MEDICAL Evidence-Based Medicine. MEDICAL Internal Medicine. Diabetic nephropathies |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1488015 |
| work_keys_str_mv | AT limingxi diabeticnephropathyfrombenchtobedside AT taojianling diabeticnephropathyfrombenchtobedside |